Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes

Bibliographic Details
Main Authors: Messori, Andrea, Fadda, Valeria, Maratea, Dario, Trippoli, Sabrina, Marinai, Claudio
Format: Online
Language:English
Published: Springer Healthcare 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065299/
id pubmed-4065299
recordtype oai_dc
spelling pubmed-40652992014-06-25 Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes Messori, Andrea Fadda, Valeria Maratea, Dario Trippoli, Sabrina Marinai, Claudio Brief Report Springer Healthcare 2014-05-03 2014-06 /pmc/articles/PMC4065299/ /pubmed/24793219 http://dx.doi.org/10.1007/s13300-014-0066-y Text en © The Author(s) 2014
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Messori, Andrea
Fadda, Valeria
Maratea, Dario
Trippoli, Sabrina
Marinai, Claudio
spellingShingle Messori, Andrea
Fadda, Valeria
Maratea, Dario
Trippoli, Sabrina
Marinai, Claudio
Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
author_facet Messori, Andrea
Fadda, Valeria
Maratea, Dario
Trippoli, Sabrina
Marinai, Claudio
author_sort Messori, Andrea
title Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
title_short Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
title_full Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
title_fullStr Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
title_full_unstemmed Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
title_sort testing the therapeutic equivalence of alogliptin, linagliptin, saxagliptin, sitagliptin or vildagliptin as monotherapy or in combination with metformin in patients with type 2 diabetes
description
publisher Springer Healthcare
publishDate 2014
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065299/
_version_ 1612104323894870016

Similar Items